“Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) With PF-Pembrolizumab”. Voprosy Onkologii, vol. 70, no. 6, Jan. 2025, pp. 1096-05, https://doi.org/10.37469/0507-3758-2024-70-6-1096-1105.